Moderate to Severe Persistent Asthma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Moderate to Severe Persistent Asthma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07342803

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

This is a multicenter, randomized, masked, active and placebo controlled, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetics of LP-0…

China200 participantsStarted 2025-01-25

Treatment: LP-003 Injection, Omalizumab

All recent trials (39 shown)

TerminatedPhase 1

NCT05035862

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

This study is a two strata, dose escalation Phase I clinical trial designed to assess the safety and determine the maximal tolerated dose (MTD) of allogenic cor…

United States1 participantsStarted 2022-03-16

Treatment: Albuterol Sulfate, Interferon gamma-primed mesenchymal stromal cells (MSCs)

CompletedPhase 3

NCT04233190

A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

A phase III study, multicenter, randomized, parallel, open, two-period, comparative non-inferiority of Eurofarma versus Alenia® in the treatment of moderate to…

Brazil472 participantsStarted 2023-04-19

Treatment: Alenia® 12mcg + 400mcg / Alenia® 6mcg + 200mcg

Moderate to Severe Persistent Asthma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

All recent trials (39 shown)

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

All recent trials (39 shown)

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

Asthma In-Home Monitoring (AIM) Trial

Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asth…

EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA

An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Dose Finding Study for QAW039 in Asthma

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µ…

EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125…

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticaso…

Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (…

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/D…

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma